APA (7th ed.) Citation

Berwick, D. C., Javaheri, B., Wetzel, A., Hopkinson, M., Nixon-Abell, J., Grannò, S., . . . Harvey, K. (2017). Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of β-catenin signaling. Molecular Neurodegeneration, 12, 1. https://doi.org/10.1186/s13024-017-0153-4

Chicago Style (17th ed.) Citation

Berwick, Daniel C., Behzad Javaheri, Andrea Wetzel, Mark Hopkinson, Jonathon Nixon-Abell, Simone Grannò, Andrew A. Pitsillides, and Kirsten Harvey. "Pathogenic LRRK2 Variants Are Gain-of-function Mutations That Enhance LRRK2-mediated Repression of β-catenin Signaling." Molecular Neurodegeneration 12 (2017): 1. https://doi.org/10.1186/s13024-017-0153-4.

MLA (9th ed.) Citation

Berwick, Daniel C., et al. "Pathogenic LRRK2 Variants Are Gain-of-function Mutations That Enhance LRRK2-mediated Repression of β-catenin Signaling." Molecular Neurodegeneration, vol. 12, 2017, p. 1, https://doi.org/10.1186/s13024-017-0153-4.